Filippseyjar - enska - FDA (Food And Drug Administration)

hospira philippines, inc. - meropenem (as trihydrate) - powde for injection / infusion - 1g

Filippseyjar - enska - FDA (Food And Drug Administration)

hospira philippines, inc. - oxaliplatin - solution for infusion (iv) - 5mg / ml

Filippseyjar - enska - FDA (Food And Drug Administration)

hospira philippines, inc. - pamidronate disodium - solution for injection (iv infusion) - 3mg / ml (0.3% w / v)

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

hospira pty limited - cefazolin sodium -

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

hospira pty limited - cefoxitin sodium -

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

hospira pty limited - ceftriaxone sodium -

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - head and neck cancer, small cell lung cancer, testicular cancer, ovarian cancer, uterine cancer, malignant lymphoma, non-small cell lung cancer, breast cancer used in conjunction with other antineoplastic drugs for the following malignant tumours: paediatric solid malignant tumours (neuroblastoma/retinoblastoma/ hepatoblastoma/central nervous system neuroblastoma, recurrent or refractory ewing?s sarcoma family tumours/nephroblastoma)

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - head and neck cancer, small cell lung cancer, testicular cancer, ovarian cancer, uterine cancer, malignant lymphoma, non-small cell lung cancer, breast cancer used in conjunction with other antineoplastic drugs for the following malignant tumours: paediatric solid malignant tumours (neuroblastoma/retinoblastoma/ hepatoblastoma/central nervous system neuroblastoma, recurrent or refractory ewing?s sarcoma family tumours/nephroblastoma)

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - head and neck cancer, small cell lung cancer, testicular cancer, ovarian cancer, uterine cancer, malignant lymphoma, non-small cell lung cancer, breast cancer used in conjunction with other antineoplastic drugs for the following malignant tumours: paediatric solid malignant tumours (neuroblastoma/retinoblastoma/ hepatoblastoma/central nervous system neuroblastoma, recurrent or refractory ewing?s sarcoma family tumours/nephroblastoma)

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - epirubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - 1. relief of subjective and objective symptoms in the following diseases: acute leukaemia, malignant lymphoma, breast cancer, ovarian cancer, stomach cancer, liver cancer, urothelial cancer (bladder cancer, renal pelvic/ureteral cancer) 2. treatment of the following malignant cancer in conjunction with other anti-malignant cancer drugs: breast cancer (pre- and post-operative chemotherapy in operable cases)